CardioExchange Archive

November 19th, 2012

Selections from Richard Lehman’s Literature Review: November 19th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include multivitamins and cancer prevention in men, a comparison of atorvastatin with or without a PCSK9 Antibody in primary hypercholesterolemia, type-2 diabetes screening and population mortality over 10 years, and more.

---

November 12th, 2012

Selections from Richard Lehman’s Literature Review: November 12th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include multivitamins for the prevention of CVD in men, the TRILOGY ACS trial, statin use and reduced cancer mortality, and more.

---

November 5th, 2012

Selections from Richard Lehman’s Literature Review: November 5th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include fish consumption, omega-3 fatty acids, and cerebrovascular disease; HRT and cardiovascular disease in recently menopausal women; and more.

---

October 29th, 2012

Selections from Richard Lehman’s Literature Review: October 29th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include CV risk factors and peripheral artery disease in men, radiofrequency ablation in paroxysmal AF, CPR duration and survival after in-hospital cardiac arrest, an everolimus-eluting stent vs. a bare-metal stent in STEMI, job strain and CHD, and more.

---

October 22nd, 2012

Selections from Richard Lehman’s Literature Review: October 22nd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include favorable lipid-level trends in U.S. adults, an angiotensin receptor neprilysin inhibitor for patients with HF and preserved systolic ejection fraction, and a long-term safety comparison of the Zotarolimus-eluting and Sirolimus-eluting coronary stents.

---

October 15th, 2012

Selections from Richard Lehman’s Literature Review: October 15th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include PCI use in states with public reporting of outcomes; proneurotensin as a prognostic marker for CVD, diabetes, and mortality; vorapaxar for secondary prevention of thrombotic events in patients with previous MI; and atenolol vs. metoprolol for hypertension.

---

October 8th, 2012

Selections from Richard Lehman’s Literature Review: October 8th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include beta-blockers and the lack of a cardioprotective effect for certain patients; intra-aortic balloon support for MI with cardiogenic shock; prasugrel vs. clopidogrel for acute coronary syndromes without revascularization; CRP, fibrinogen, and CVD prediction; and a comparison of thrombectomy devices for acute ischemic stroke.

---

October 1st, 2012

Selections from Richard Lehman’s Literature Review: October 1st

Richard Lehman, BM, BCh, MRCGP

This week’s topics include exercise and mortality in those with diabetes, BP targets in those with type-2 diabetes, and the diagnostic accuracy of FFR from CT angiography.

---

September 24th, 2012

Selections from Richard Lehman’s Literature Review: September 24th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include papers on punishing health care fraud, how physicians interpret research funding disclosures, and the association between BP and mortality in those newly diagnosed with type-2 diabetes.

---

September 17th, 2012

Selections from Richard Lehman’s Literature Review: September 17th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include surgical vs. lifestyle treatment for type-2 diabetes, omega-3 fatty-acid supplementation and the risk for major CVD events, FAME 2, using high-sensitivity cardiac troponin T for one-hour rule-out or rule-in of acute MI, and the timing of acute MI in patients having total hip or knee replacement.

---